PERTH (Reuters) - Opener Aaron Finch retired hurt after being hit on his right index finger by India quick Mohammed Shami as Australia reached tea on 33 without loss and a lead of 76 runs in the second test on Sunday.
Reported by SBS 25 minutes ago.
Cricket: Finch hurt as Australia extend lead to 76 in Perth
↧
↧
'Missed opportunity': Australia's 'difficult' position in UN climate change talks
Australia's "constructive" role at the United Nations climate change talks in Poland was undermined by its continued support for fossil fuels at home, experts say.
Reported by Brisbane Times 31 minutes ago.
↧
Japanese brand Miniso planning to source Indian products to Australia, US
Japanese retail brand Miniso plans to source India-made products for its stores in the US and Australia, said a top company official.
Reported by DNA 5 minutes ago.
↧
Sport24.co.za | Finch retires hurt as Australia build lead over India
Aaron Finch retired hurt after being struck on the finger as Australia built a 76-run lead over India during the second Test in Perth.
Reported by News24 7 minutes ago.
↧
Johnson arrival curbs Cheika's powers
Rugby Australia has appointed former Wallabies assistant coach Scott Johnson as its director of rugby to help coach Michael Cheika before the 2019 World Cup,
Reported by SBS 2 hours ago.
↧
↧
Cricket-India chase 287 to win second test
India need 287 runs on a menacing Perth Stadium pitch to win the second test after Australia were all out for 243 in the middle session on the fourth day on Monday.
Reported by Reuters India 1 hour ago.
↧
Michael Cheika survives as Australia coach ahead of Rugby World Cup
Rugby Australia has confirmed Michael Cheika will lead Australia to next year's World Cup but from now on will work under the supervision of Scott Johnson, who takes a new role as director of rugby.
Reported by MailOnline 34 minutes ago.
↧
Cricket: India chase 287 to win second test
India need 287 runs on a menacing Perth Stadium pitch to win the second test after Australia were all out for 243 in the middle session on the fourth day on Monday.
Reported by Reuters India 56 minutes ago.
↧
GC Rieber Shipping: Last day of subscription period today
Stock Exchange Notice
Date: 17 December 2018
*GC Rieber Shipping ASA: Last day of subscription period today*
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES, OR IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.
Reference is made to the previous stock exchange announcements by GC Rieber Shipping ASA ("GC Rieber Shipping" or the "Company") in respect of the rights issue (the "Rights Issue") of 28,941,177 new shares in the Company (the "Offer Shares") at a subscription price of NOK 8.50 per Offer Share.
The subscription period for the Rights Issue will expire today, 17 December 2018, at 16:30 hours (CET).
Correctly completed subscription forms must be received by the subscription office as set out in the prospectus dated 29 November 2018 (the "Prospectus"), or, in case of online subscriptions through the VPS online subscription system, be registered, within this deadline.
Subscription rights that are not used to subscribe for Offer Shares within this deadline will have no value and lapse without compensation to the holder.
For further details of the terms of the Rights Issue, please refer to the Prospectus.
*For further information, please contact:*
CEO Einar Ytredal, phone: +47 975 20 184
CFO Øystein Kvåle, phone: +47 479 02 919
*About GC Rieber Shipping:*
GC Rieber Shipping's business within offshore/shipping includes ownership in specialized vessels, high quality marine ship management and project development within the segments subsea, ice/support and marine seismic.
The group has a specialized competence in offshore operations in harsh environments as well as design, development and maritime operation of offshore vessels. GC Rieber Shipping currently operates 11 and has direct and indirect ownership in 23 advanced special purpose vessels for defined markets within the subsea, ice/support and marine seismic segments.
The company has its headquarter and a ship management office in Bergen, and an additional ship management company in Yuzhno-Sakhalinsk (Russia). The Company is listed on Oslo Børs with ticker RISH.
Further information is available on the company's website www.gcrieber-shipping.com.
*IMPORTANT INFORMATION*
This communication may not be published, distributed or transmitted in or into the United States, Canada, Australia or Japan. These materials do not constitute or form a part of any offer or solicitation to purchase or subscribe for securities of the Company in the United States, Norway or any other jurisdiction. The securities of the Company may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"). The securities of the Company have not been, and will not be, registered under the U.S. Securities Act. Any sale in the United States of the securities mentioned in this communication will be made solely to "qualified institutional buyers" as defined in Rule 144A under the U.S. Securities Act and to "major U.S. institutional investors" under SEC Rule 15a-6 to the United States Exchange Act of 1934. No public offering of the securities will be made in the United States.
In any EEA Member State that has implemented the Prospectus Directive, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive, i.e., only to investors who can receive the offer without an approved prospectus in such EEA Member State. The expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto, including Directive 2010/73/EU, to the extent implemented in any relevant Member State) and includes any relevant implementing measure in the relevant Member State.
In the United Kingdom, this communication is only addressed to and is only directed at Qualified Investors who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") or (ii) are persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, unincorporated associations, etc.) (all such persons together being referred to as "Relevant Persons"). These materials are directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this announcement relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. Persons distributing this communication must satisfy themselves that it is lawful to do so.
Matters discussed in this announcement may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "anticipate", "believe", "continue", "estimate", "expect", "intends", "may", "should", "will" and similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The information, opinions and forward-looking statements contained in this announcement speak only as at its date, and are subject to change without notice.
This announcement is made by and, and is the responsibility of, the Company. SpareBank 1 Markets AS (the "Manager") is acting exclusively for the Company and no one else and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients, or for advice in relation to the contents of this announcement or any of the matters referred to herein.
Neither the Manager nor any of its affiliates makes any representation as to the accuracy or completeness of this announcement and none of them accepts any responsibility for the contents of this announcement or any matters referred to herein.
This announcement is for information purposes only and is not to be relied upon in substitution for the exercise of independent judgment. It is not intended as investment advice and under no circumstances is it to be used or considered as an offer to sell, or a solicitation of an offer to buy any securities or a recommendation to buy or sell any securities of the Company. Neither the Manager nor any of its affiliates accepts any liability arising from the use of this announcement.
Each of the Company, the Manager and their respective affiliates expressly disclaims any obligation or undertaking to update, review or revise any statement contained in this announcement whether as a result of new information, future developments or otherwise.
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act. Reported by GlobeNewswire 1 hour ago.
Date: 17 December 2018
*GC Rieber Shipping ASA: Last day of subscription period today*
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES, OR IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.
Reference is made to the previous stock exchange announcements by GC Rieber Shipping ASA ("GC Rieber Shipping" or the "Company") in respect of the rights issue (the "Rights Issue") of 28,941,177 new shares in the Company (the "Offer Shares") at a subscription price of NOK 8.50 per Offer Share.
The subscription period for the Rights Issue will expire today, 17 December 2018, at 16:30 hours (CET).
Correctly completed subscription forms must be received by the subscription office as set out in the prospectus dated 29 November 2018 (the "Prospectus"), or, in case of online subscriptions through the VPS online subscription system, be registered, within this deadline.
Subscription rights that are not used to subscribe for Offer Shares within this deadline will have no value and lapse without compensation to the holder.
For further details of the terms of the Rights Issue, please refer to the Prospectus.
*For further information, please contact:*
CEO Einar Ytredal, phone: +47 975 20 184
CFO Øystein Kvåle, phone: +47 479 02 919
*About GC Rieber Shipping:*
GC Rieber Shipping's business within offshore/shipping includes ownership in specialized vessels, high quality marine ship management and project development within the segments subsea, ice/support and marine seismic.
The group has a specialized competence in offshore operations in harsh environments as well as design, development and maritime operation of offshore vessels. GC Rieber Shipping currently operates 11 and has direct and indirect ownership in 23 advanced special purpose vessels for defined markets within the subsea, ice/support and marine seismic segments.
The company has its headquarter and a ship management office in Bergen, and an additional ship management company in Yuzhno-Sakhalinsk (Russia). The Company is listed on Oslo Børs with ticker RISH.
Further information is available on the company's website www.gcrieber-shipping.com.
*IMPORTANT INFORMATION*
This communication may not be published, distributed or transmitted in or into the United States, Canada, Australia or Japan. These materials do not constitute or form a part of any offer or solicitation to purchase or subscribe for securities of the Company in the United States, Norway or any other jurisdiction. The securities of the Company may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"). The securities of the Company have not been, and will not be, registered under the U.S. Securities Act. Any sale in the United States of the securities mentioned in this communication will be made solely to "qualified institutional buyers" as defined in Rule 144A under the U.S. Securities Act and to "major U.S. institutional investors" under SEC Rule 15a-6 to the United States Exchange Act of 1934. No public offering of the securities will be made in the United States.
In any EEA Member State that has implemented the Prospectus Directive, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive, i.e., only to investors who can receive the offer without an approved prospectus in such EEA Member State. The expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto, including Directive 2010/73/EU, to the extent implemented in any relevant Member State) and includes any relevant implementing measure in the relevant Member State.
In the United Kingdom, this communication is only addressed to and is only directed at Qualified Investors who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") or (ii) are persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, unincorporated associations, etc.) (all such persons together being referred to as "Relevant Persons"). These materials are directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this announcement relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. Persons distributing this communication must satisfy themselves that it is lawful to do so.
Matters discussed in this announcement may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "anticipate", "believe", "continue", "estimate", "expect", "intends", "may", "should", "will" and similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The information, opinions and forward-looking statements contained in this announcement speak only as at its date, and are subject to change without notice.
This announcement is made by and, and is the responsibility of, the Company. SpareBank 1 Markets AS (the "Manager") is acting exclusively for the Company and no one else and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients, or for advice in relation to the contents of this announcement or any of the matters referred to herein.
Neither the Manager nor any of its affiliates makes any representation as to the accuracy or completeness of this announcement and none of them accepts any responsibility for the contents of this announcement or any matters referred to herein.
This announcement is for information purposes only and is not to be relied upon in substitution for the exercise of independent judgment. It is not intended as investment advice and under no circumstances is it to be used or considered as an offer to sell, or a solicitation of an offer to buy any securities or a recommendation to buy or sell any securities of the Company. Neither the Manager nor any of its affiliates accepts any liability arising from the use of this announcement.
Each of the Company, the Manager and their respective affiliates expressly disclaims any obligation or undertaking to update, review or revise any statement contained in this announcement whether as a result of new information, future developments or otherwise.
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act. Reported by GlobeNewswire 1 hour ago.
↧
↧
Olainfarm Group Sales in November Grew By 8%
*Preliminary consolidated results of JSC Olainfarm for November 2018 show that total sales of the Group have reached 10.9 million euros, which represents 8% increase compared to the same period of 2018. During the eleven months, sales of the Olainfarm Group have grown by 7%, reaching 112.6 million euros. In 11- month, period Olainfarm Group has sold its products in 52 markets worldwide.*
Consolidated data
Consolidated sales data for November show that the fastest growth in November was recorded in the Netherlands, Moldova, Belarus and Kazakhstan, where turnover grew by 474%, 98%, 67% and 52%, respectively. Sales to Uzbekistan in November decreased by 34%; 15% reduction was also marked in Ukraine, which can be explained by the orderly nature of orders. In November 2018, Olainfarm’s largest outlets were Russia, Latvia and Ukraine. In total Olainfarm products in November were sold in 33 markets.
The fastest sales growth in eleven months of this year has been observed in Belarus and Tajikistan, where sales increased by 53% and 52%, respectively. A significant increase by 31% compared to the last year has also been achieved in Uzbekistan. Sales in Russia in 11 months have decreased by 5%, while sales in Latvia have risen by 18%, but in Lithuania by 23%.
*November 2018, consolidated sales* *Sales, thsnd. EUR* *Changes to November 2017* *Share in total sales*
Russia 3 454 -3% 32%
Latvia 3288 24% 30%
Ukraine 1309 -15% 12%
Belarus 871 67% 8%
Kazakhstan 291 52% 3%
Uzbekistan 196 -34% 2%
Germany 161 2% 1%
Netherlands 145 474% 1%
Lithuania 142 16% 1%
Moldova 139 98% 1%
Other 924 -1% 8%
Total 10 920 8% 100%
*11 months of 2018, consolidated sales * *Sales, thsnd. EUR* *Changes to 11 months of 2017* *Share in total sales *
Russia 33 716 -5% 30%
Latvia 31 827 18% 28%
Belarus 13 336 53% 12%
Ukraine 10 640 5% 9%
Kazakhstan 3 070 5% 3%
Uzbekistan 2 219 31% 2%
Germany 1 768 3% 2%
Lithuania 1 703 23% 2%
Poland 1 385 8% 1%
Tajikistan 1 300 52% 1%
Other 11 591 -18% 10%
Total 112 556 7% 100%
Unconsolidated data
According to the preliminary unconsolidated results, sales of JSC Olainfarm during November 2018 reached 7.97 million euros, which is similar to the 11-month sales results of 2017. The largest increase in sales in November was recorded in the Netherlands and Poland, where sales grew by 474% and 254%, respectively. In November, sales fell by 8% in Russia, while sales in Ukraine dropped by 19% compared to the last November. A decrease of 34% was also noted in Uzbekistan. In November 2018, Olainfarm’s products were sold in 30 countries worldwide.
According to unconsolidated 11-month results, sales of Olainfarm in Belarus have increased by 27%, in Latvia by 17%, in Ukraine by 5%, while sales in Russia have felt by 10% compared to 11 months of 2017. The largest increase in sales over the reporting period has been achieved in Tajikistan, Lithuania and Uzbekistan, where turnover grew by 59%, 35% and 31%, respectively. In total, during the eleven months of 2018, JSC Olainfarm products were sold in 46 countries.
*November 2018, unconsolidated sales * *Sales, thsnd. EUR* *Changes to November 2017* *Share in total sales*
Russia 2 923 -8% 37%
Latvia 1 616 18% 20%
Ukraine 1 249 -19% 16%
Belarus 622 24% 8%
Uzbekistan 196 -34% 2%
Germany 160 17% 2%
The Netherlands 145 474% 2%
Lithuania 135 14% 2%
Poland 122 254% 2%
Kazakhstan 119 4% 1%
Other 708 12% 9%
Total 7 996 0% 100%
*11 months of 2018, unconsolidated sales * *Sales, thsnd. EUR* *Changes to 11 months of 2017* *Share in total sales *
Russia 29 124 -10% 34%
Latvia 15 675 17% 18%
Ukraine 10 970 27% 13%
Belarus 10 430 5% 12%
Uzbekistan 2 219 31% 3%
Kazakhstan 1 990 0% 2%
Germany 1 752 5% 2%
Lithuania 1 573 35% 2%
Tajikistan 1 267 59% 1%
Poland 1 043 3% 1%
Other 9 358 -18% 11%
Total 85 401 2% 100%
Performance of daughter companies in November and 11- months period
Sales of pharmacies of SIA Latvijas Aptieka* in November 2018* reached 2.1 million euros which represents an increase of 11% vs. the November 2017. 69 pharmacies were operating during September. Sales of Silvanols in November reached 0.51 million euros ans increased by 13%. Combined sales of Tonus Elast and its Russian sales arm Elast Medical were 1.05 million euros. Combined sales of healthcare companies Diamed and Olainmed in November reached 0.25 million euros. Sales of NPK Biotest in November 2018 reached 0.20 million euros.
Sales of pharmacies of SIA Latvijas aptieka *in 11- months* of 2018 reached 21.4 million euros, which represents an increase of 9% compared to the same period of 2017. Sales of SIA Silvanols in 11-months were 5.5 million euros and demonstrated a 16% increase in comparison to the same period of the last year. Sales of SIA Tonus Elast in eleven months period reached 9.2 million euros. Combined 11-month sales of healthcare companies Diamed and Olainmed reached 2.4 million euros, but sales of NPK Biotest – 2.1 million euros.
According to the estimates of JSC Olainfarm, the unconsolidated turnover of the company in 2018 could reach 96 million euros, while the consolidated turnover - 130 million euros. According to the preliminary turnover figures published here, in the 11-months of 2018, 88% of the total unconsolidated turnover planned for 2018 and 83% of the planned annual consolidated turnover has been achieved.
--------------------
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top- quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 60 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Inga Krukle
Board Member, JSC Olainfarm
Ph. +371 28698449
Inga.krukle@olainfarm.com Reported by GlobeNewswire 1 hour ago.
Consolidated data
Consolidated sales data for November show that the fastest growth in November was recorded in the Netherlands, Moldova, Belarus and Kazakhstan, where turnover grew by 474%, 98%, 67% and 52%, respectively. Sales to Uzbekistan in November decreased by 34%; 15% reduction was also marked in Ukraine, which can be explained by the orderly nature of orders. In November 2018, Olainfarm’s largest outlets were Russia, Latvia and Ukraine. In total Olainfarm products in November were sold in 33 markets.
The fastest sales growth in eleven months of this year has been observed in Belarus and Tajikistan, where sales increased by 53% and 52%, respectively. A significant increase by 31% compared to the last year has also been achieved in Uzbekistan. Sales in Russia in 11 months have decreased by 5%, while sales in Latvia have risen by 18%, but in Lithuania by 23%.
*November 2018, consolidated sales* *Sales, thsnd. EUR* *Changes to November 2017* *Share in total sales*
Russia 3 454 -3% 32%
Latvia 3288 24% 30%
Ukraine 1309 -15% 12%
Belarus 871 67% 8%
Kazakhstan 291 52% 3%
Uzbekistan 196 -34% 2%
Germany 161 2% 1%
Netherlands 145 474% 1%
Lithuania 142 16% 1%
Moldova 139 98% 1%
Other 924 -1% 8%
Total 10 920 8% 100%
*11 months of 2018, consolidated sales * *Sales, thsnd. EUR* *Changes to 11 months of 2017* *Share in total sales *
Russia 33 716 -5% 30%
Latvia 31 827 18% 28%
Belarus 13 336 53% 12%
Ukraine 10 640 5% 9%
Kazakhstan 3 070 5% 3%
Uzbekistan 2 219 31% 2%
Germany 1 768 3% 2%
Lithuania 1 703 23% 2%
Poland 1 385 8% 1%
Tajikistan 1 300 52% 1%
Other 11 591 -18% 10%
Total 112 556 7% 100%
Unconsolidated data
According to the preliminary unconsolidated results, sales of JSC Olainfarm during November 2018 reached 7.97 million euros, which is similar to the 11-month sales results of 2017. The largest increase in sales in November was recorded in the Netherlands and Poland, where sales grew by 474% and 254%, respectively. In November, sales fell by 8% in Russia, while sales in Ukraine dropped by 19% compared to the last November. A decrease of 34% was also noted in Uzbekistan. In November 2018, Olainfarm’s products were sold in 30 countries worldwide.
According to unconsolidated 11-month results, sales of Olainfarm in Belarus have increased by 27%, in Latvia by 17%, in Ukraine by 5%, while sales in Russia have felt by 10% compared to 11 months of 2017. The largest increase in sales over the reporting period has been achieved in Tajikistan, Lithuania and Uzbekistan, where turnover grew by 59%, 35% and 31%, respectively. In total, during the eleven months of 2018, JSC Olainfarm products were sold in 46 countries.
*November 2018, unconsolidated sales * *Sales, thsnd. EUR* *Changes to November 2017* *Share in total sales*
Russia 2 923 -8% 37%
Latvia 1 616 18% 20%
Ukraine 1 249 -19% 16%
Belarus 622 24% 8%
Uzbekistan 196 -34% 2%
Germany 160 17% 2%
The Netherlands 145 474% 2%
Lithuania 135 14% 2%
Poland 122 254% 2%
Kazakhstan 119 4% 1%
Other 708 12% 9%
Total 7 996 0% 100%
*11 months of 2018, unconsolidated sales * *Sales, thsnd. EUR* *Changes to 11 months of 2017* *Share in total sales *
Russia 29 124 -10% 34%
Latvia 15 675 17% 18%
Ukraine 10 970 27% 13%
Belarus 10 430 5% 12%
Uzbekistan 2 219 31% 3%
Kazakhstan 1 990 0% 2%
Germany 1 752 5% 2%
Lithuania 1 573 35% 2%
Tajikistan 1 267 59% 1%
Poland 1 043 3% 1%
Other 9 358 -18% 11%
Total 85 401 2% 100%
Performance of daughter companies in November and 11- months period
Sales of pharmacies of SIA Latvijas Aptieka* in November 2018* reached 2.1 million euros which represents an increase of 11% vs. the November 2017. 69 pharmacies were operating during September. Sales of Silvanols in November reached 0.51 million euros ans increased by 13%. Combined sales of Tonus Elast and its Russian sales arm Elast Medical were 1.05 million euros. Combined sales of healthcare companies Diamed and Olainmed in November reached 0.25 million euros. Sales of NPK Biotest in November 2018 reached 0.20 million euros.
Sales of pharmacies of SIA Latvijas aptieka *in 11- months* of 2018 reached 21.4 million euros, which represents an increase of 9% compared to the same period of 2017. Sales of SIA Silvanols in 11-months were 5.5 million euros and demonstrated a 16% increase in comparison to the same period of the last year. Sales of SIA Tonus Elast in eleven months period reached 9.2 million euros. Combined 11-month sales of healthcare companies Diamed and Olainmed reached 2.4 million euros, but sales of NPK Biotest – 2.1 million euros.
According to the estimates of JSC Olainfarm, the unconsolidated turnover of the company in 2018 could reach 96 million euros, while the consolidated turnover - 130 million euros. According to the preliminary turnover figures published here, in the 11-months of 2018, 88% of the total unconsolidated turnover planned for 2018 and 83% of the planned annual consolidated turnover has been achieved.
--------------------
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top- quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 60 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Inga Krukle
Board Member, JSC Olainfarm
Ph. +371 28698449
Inga.krukle@olainfarm.com Reported by GlobeNewswire 1 hour ago.
↧
UPDATE 1-Cricket-India two down early chasing 287 runs
India made a poor start to their daunting run chase in the second test losing the key wickets of Lokesh Rahul and Cheteshwar Pujara before tea on the fourth day with Australia's fired-up quicks smelling blood on a menacing pitch on Monday.
Reported by Reuters India 36 minutes ago.
↧
PHOTOS: Australia vs India, 2nd Test, Day 4
IMAGES from Day 3 of the 2nd Test at Perth on Monday
Reported by Rediff.com 1 hour ago.
↧
Cricket: India two down early chasing 287 runs
India made a poor start to their daunting run chase in the second test losing the key wickets of Lokesh Rahul and Cheteshwar Pujara before tea on the fourth day with Australia's fired-up quicks smelling blood on a menacing pitch on Monday.
Reported by Reuters India 34 minutes ago.
↧
↧
Johnson gets big rap from Scotland boss
Australia's new director of rugby Scott Johnson has been hailed for his unrivalled global knowledge in the sport by his boss at Scottish Rugby.
Reported by SBS 41 minutes ago.
↧
Australia: The interlock program for drink driving in NSW – a basic guide - Stacks Law Firm
For drink driving offences, a court imposes a licence disqualification period and participation in the interlock program.
Reported by Mondaq 51 minutes ago.
↧
Labor makes promises on refugees, Newstart
Bill Shorten has promised to bring 4000 more refugees to Australia each year and urgently reviewing the level of Newstart in a bid to soothe factional tensions.
Reported by SBS 27 minutes ago.
↧
Mum's ingenious £2 cleaning trick that has transformed her stained furniture
The woman from Queensland, Australia, revealed her method on Facebook group Mums Who Clean, sharing photos of a sofa that now looks unrecognisable
Reported by Daily Record 10 minutes ago.
↧
↧
IND vs AUS 2nd Test, Day 4: India make poor start in stiff chase of 287 at Perth
India need 287 runs in their second innings to win the Perth Test match against Australia.
Reported by DNA 32 minutes ago.
↧
Australia: Can an unsent text message be a valid will? Which case won? - Stacks Law Firm
This case highlights the importance of preparing a formal will in order to prevent lengthy and expensive litigation.
Reported by Mondaq 39 minutes ago.
↧
India vs Australia 2nd Test: Mohammed Shami takes 6 wickets, breaks Anil Kumble's 12 year old record
Mohammed Shami produced his career best figures in Perth Test match.
Reported by DNA 19 minutes ago.
↧
More Pages to Explore .....
